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Abstract
Background: The concept of reserve was established to account for the observation that a given degree of
neurodegenerative pathology may result in varying degrees of symptoms in different individuals. There is a large
amount of evidence on epidemiological risk and protective factors for neurodegenerative diseases and dementia,
yet the biological mechanisms that underpin the protective effects of certain lifestyle and physiological variables
remain poorly understood, limiting the development of more effective preventive and treatment strategies.
Additionally, different definitions and concepts of reserve exist, which hampers the coordination of research and
comparison of results across studies.
Discussion: This paper represents the consensus of a multidisciplinary group of experts from different areas of
research related to reserve, including clinical, epidemiological and basic sciences. The consensus was developed
during meetings of the working groups of the first International Conference on Cognitive Reserve in the Dementias
(24–25 November 2017, Munich, Germany) and the Alzheimer’s Association Reserve and Resilience Professional
Interest Area (25 July 2018, Chicago, USA). The main objective of the present paper is to develop a translational
perspective on putative mechanisms underlying reserve against neurodegenerative disease, combining evidence
from epidemiological and clinical studies with knowledge from animal and basic research. The potential brain
functional and structural basis of reserve in Alzheimer’s disease and other brain disorders are discussed, as well as
relevant lifestyle and genetic factors assessed in both humans and animal models.
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Conclusion: There is an urgent need to advance our concept of reserve from a hypothetical model to a more
concrete approach that can be used to improve the development of effective interventions aimed at preventing
dementia. Our group recommends agreement on a common dictionary of terms referring to different aspects of
reserve, the improvement of opportunities for data sharing across individual cohorts, harmonising research approaches
across laboratories and groups to reduce heterogeneity associated with human data, global coordination of clinical
trials to more effectively explore whether reducing epidemiological risk factors leads to a reduced burden of
neurodegenerative diseases in the population, and an increase in our understanding of the appropriateness of animal
models for reserve research.
Keywords: Alzheimer’s disease, Parkinson’s disease, neuroimaging, biomarkers, risk factors, animal models, prevention,
epidemiology, cognitive reserve, brain reserve
Background
The current paper presents the common consensus of the
working groups of the first International Conference on
Cognitive Reserve in the Dementias, held on November
24–25, 2017, at the Department of Psychiatry and
Psychotherapy of the University Hospital of Ludwig
Maximilian University, Munich, Germany, and the
Alzheimer’s Association Reserve and Resilience Professional
Interest Area, which held its last meeting on July 25, 2018,
at the Alzheimer’s Association International Conference in
Chicago, IL, USA.
Dementia is becoming more prevalent globally, with
the associated burden on societies and healthcare sys-
tems constantly increasing [1]. Since the approval of the
cholinesterase inhibitors and memantine more than two
decades ago [2, 3], further attempts to develop new
drugs for dementia have failed. Conversely, research and
development efforts in other fields of medicine, such as
cancer, have been more successful, primarily due to
more advanced approaches that utilise the power of
large cohorts to identify new study endpoints and drug
candidates [4]. Therefore, a cultural transformation of
the dementia research field is urgently required to repli-
cate successes in other disease areas [5].
Similar to most other complex diseases, the aetiology of
the prevalent neurodegenerative dementias is multifactor-
ial and influenced by a range of diverse parameters such
as lifestyle, genetics, an individual’s personality, behav-
ioural decisions and external factors [6]. While genetic
susceptibility is largely hereditary and cannot be modified,
risk conferred by the environment (including epigenetic
mechanisms) can potentially be altered. Indeed, lifestyle
changes (e.g. leading to reduced vascular risk) may be an
appropriate means to prevent or delay dementia and neu-
rodegenerative changes [7]. Additionally, the role of pro-
tective factors is increasingly being recognised, with
improved physical and psychological wellbeing through
healthier diets and more active lifestyles also likely con-
tributing to dementia prevention. Finally, personality traits
(e.g. higher neuroticism) [8] and external factors, such as
air pollution and healthcare systems, may also be associ-
ated with dementia risk [9] (Fig. 1).
Research on protective factors for different dementias
has received growing attention in recent years. A key find-
ing was that higher levels of lifelong experiences, such as
cognitive, social and physical activities [10], are associated
with a later onset and decreased risk of dementia, which
may to some extent explain the reduced age-associated de-
mentia incidence recently reported in some high-income
countries [11]. However, the biological mechanisms under-
lying these protective effects remain largely unknown;
improving our mechanistic understanding of these effects
is crucial for the development of effective therapies and
preventive strategies.
The main aim of the present paper is to develop a trans-
lational perspective on the putative mechanisms underlying
reserve against neurodegenerative disease, combining evi-
dence from epidemiological and clinical studies with know-
ledge from animal and basic science research (Fig. 2). Given
the high complexity and multifactorial aetiology associated
with neurodegenerative dementias, an approach to study
reserve, which integrates the most recent evidence from
the relevant disciplines across the traditional boundaries of
the different dementia types, seems promising. Herein, we
discuss the brain structural and functional underpinnings
of reserve as well as relevant genetic factors and lifestyles,
both in humans and in animal models. Further, the similar-
ities and differences between different neuropsychiatric
disorders such as Alzheimer’s disease (AD), Parkinson’s dis-
ease, frontotemporal dementia (FTD), multiple sclerosis
(MS) and schizophrenia (SZ) are addressed. Finally, the
challenges and opportunities in relation to the design of
future observational and interventional studies, with the
ultimate aim to strengthen reserve and to improve demen-
tia prevention, are also discussed.
Conceptual considerations
The concept of reserve was introduced to help explain
the disjunction between the degree of observed brain
changes or pathology and the clinical manifestation of
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Fig. 1 A multicausal model of neurodegenerative dementias (modified from Perneczky [20])
Fig. 2 Translational model of reserve against neurodegenerative disease
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those brain changes. At this point, three important con-
cepts have emerged, namely brain reserve (BR), brain
maintenance (BM) and cognitive reserve (CR) [10, 12, 13].
These concepts were recently defined and discussed in a
consensus whitepaper [14].
BR points to the idea that individuals with more
neurobiological capital, such as more synapses or neu-
rons, do better in the face of age-related or pathologic
brain changes. In the landmark article by Blessed et al.
in 1968 [15], the authors noted that six subjects had a
dementia score near 0 but a high amyloid-β (Aβ) plaque
count. They speculated that “it would appear that a cer-
tain amount of the change estimated by plaque counts
may be accommodated within the reserve capacity of the
cerebrum without causing manifest intellectual impair-
ment” [15]. In the context of normal ageing, BR might
be considered a brain ‘hardware’ status such as brain vol-
ume and white matter integrity. BR has been considered
a passive process that simply involves more neurobio-
logical capital. More recently it has been recognised that
the brain is much more plastic than we originally imag-
ined. The concept of BM posits that brain integrity does
not change in the face of aging and primary pathologies.
Many lifestyle factors associated with BR also support
BM; it has been suggested that, at any point in time, BR
is a function of ongoing BM [12], i.e. BM is defined as a
longitudinal concept. Finally, CR focuses on the idea that
there are individual differences in adaptability (i.e. flexi-
bility, efficiency, capacity, compensation) of functional
brain processes that allow some people to cope better
than others with age- and disease-related brain change.
Original support for the CR concept came from epide-
miologic studies, primarily in AD. There, a reduced risk
of incident dementia was noted in individuals with
higher educational or occupational attainment [16], pre-
morbid IQ [17] and engagement in leisure activities [18].
The underlying assumption was that all of these groups
are comparable in the underlying progression of AD
pathology, and that these life experiences influenced in-
dividual differences in functional brain processes that, in
turn, moderate between pathology and clinical expres-
sion. Subsequent studies directly demonstrated that
these lifestyle factors moderated between measured AD
pathology and cognition [19, 20]. The concept of CR has
been successfully applied to normal ageing, as well as to
a host of other conditions, including HIV dementia,
Parkinson’s disease, MS and head trauma.
It is important for investigators to have consensus re-
garding the names and meanings of the concepts they
use. In this regard, there are ongoing theoretical issues
that must be addressed. For example, while BR and CR
are useful concepts for research, the conceptual differen-
tiation between brain physiology and its associated cog-
nitive processes is complex. Similarly, there are other
concepts used by investigators who explore individual dif-
ferences that need to be put into context. For example,
imaging investigators often explore the phenomenon of
compensation, with recent efforts focusing on achieving a
consensus on a set of definitions for this concept. While
some feel that exploring compensation is one approach to
understanding the neural underpinnings of CR, others
want to privilege it as a phenomenon in its own right.
It is also useful to remain aware of the context in
which these concepts were developed. The concepts of
BR and CR were initially put forward in the context of
pathologic changes such as AD and were later extended
to ‘normal’ age-related changes. In contrast, the concept
of BM has primarily been associated with age-related
brain changes. Epidemiologic studies of ageing have pro-
vided mixed results with regards to the moderating ef-
fect of factors such as education on the lifetime rate of
cognitive decline and there is evidence that early- versus
late-life education may have different effects in relation
to reserve [21]. More careful delineation of the brain
changes associated with age-related cognitive decline
may allow for more direct documentation of the pres-
ence of CR, where CR proxies moderate between these
brain changes and cognition.
Epidemiology and genetics
A series of risk and protective factors have been reported
to alter the risk for cognitive decline, mild cognitive
impairment or dementia, conceivably via reserve-related
mechanisms [22–27]. Occupation, education, literacy, and
mental, social and physical activities are some of the most
commonly described. With few exceptions, a lower inci-
dence of dementia has been reported in subjects with
higher education by most epidemiological studies around
the world [16, 22, 23, 28–35]. Education is tightly associ-
ated with the ability to perform on neuropsychological
testing, which is the main instrument used to diagnose
dementia; within a reserve framework, it has been
hypothesised that education may modify the association
between underlying neuropathology and levels of cogni-
tive function [36]. However, individuals with more formal
education may simply perform better on certain neuro-
psychological tests, and this potential circularity must be
recognised when using education as a proxy measure
for reserve.
Both education and literacy (or IQ) reflect not only
genetically determined but also environmental factors
[37–39]. However, literacy may be a better marker for
educational experiences during the lifetime than formal
education for subjects who did not have the chance to
receive formal education or to obtain an occupational
status corresponding to their abilities [40]. For example,
some individuals who were raised during war or are im-
migrants or minorities may have important intellectually
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and psychologically demanding roles in their communi-
ties, yet this status may not be reflected in years of
schooling or occupational attainment. Similarly, in many
non-western countries, for instance, in Africa and Asia,
the number of years of formal education received is
heavily influenced by (parental) income and is therefore
a poor marker of the actual reserve accrued through
multilinguistic abilities, for example. In addition, because
not only years of education but also quality of education
and non-formal education during the lifetime may differ,
measures of literacy may provide a more meaningful
proxy of reserve and should therefore be included in the
list of environmental-epidemiological factors affecting
risk for dementia. Lower linguistic, cognitive or mental
abilities (in some studies estimated quite early in life
[41]) have been associated with heavier neurodegenera-
tive pathology burden at autopsy [42], poorer cognitive
function in midlife [43], faster rates of cognitive decline
[40, 44] and higher dementia rates in late life [45, 46]. It
was also suggested that bilingualism is associated with a
lower dementia risk and that speaking two or more
languages delays the diagnosis of AD by almost 5 years
[47, 48]. Bilingual dementia patients were shown to have
greater brain atrophy compared to monolinguals, indi-
cating that they had required more severe neurodegener-
ation to develop symptoms [49]. However, a recent
systematic review and meta-analysis suggested that the
protective effects of bilingualism were more likely to be
found in retrospective compared to prospective studies,
indicating that confounding effects of factors such as
education may play a role [50].
Neuronal plasticity and development are by no means
confined to early life but may be affected in particular by
occupational experiences that occupy such a large per-
centage of our time, energy and effort during adulthood.
It has been theorised that reduced everyday experiences
and activity patterns may result in disuse and conse-
quent atrophy of cognitive processes and skills (a view
captured in the adage ‘use it or lose it’) [51, 52]. In other
words, everyday cognitive experience may affect reserve
in a manner that is analogous to physical exercise for
musculoskeletal and cardiovascular reserve functions.
Many studies have reported associations between
occupation characteristics and cognitive decline risk
[16, 22, 35, 43, 46, 53, 54]. Similarly, population-based re-
search has provided ample support for both intellectual
[28, 43, 55–63] and social [28, 53, 64–67] activities in rela-
tion to protection from future cognitive decline.
In addition to cognitive activity, there is also evidence
for protection by non-cognitive activities. Many studies
have reported that physical activities provide protection
against future cognitive decline [43, 68–73] and reduced
risk of dementia [74–77], including studies showing
effects on biomarkers related to physical activity
interventions [78, 79]. Decreased risk for cognitive de-
cline has been reported not only for strenuous [70] but
also for moderate physical activities [73, 75]. In fact, it
has been postulated that motor function has a reserve
component as well [80].
Other non-environmental factors potentially affecting
reserve may be related to individual genetic or epigenetic
characteristics. It should be noted that, although some
life experience factors that affect reserve are considered
environmental, it is possible that they may reflect some
genetic effects; indeed, single nucleotide polymor-
phisms (SNPs) associated with intelligence [81] and edu-
cation [82] have been reported. Head size or intracranial
volume is another factor related to reserve that is both
related to the (perinatal) environment [83–85] and gen-
etic variation [86]. Many of the recent genetic discover-
ies pertaining to reserve have been achieved by
genome-wide association studies (GWAS). An important
feature of such GWAS has been that increasing sample
sizes have resulted in the discovery of an increasing
number of SNPs (e.g. compare [86–89]), thereby further
unlocking the genetic underpinnings of reserve. In com-
ing years, the advent of major biobank studies, such as
the UK Biobank and German National Cohort, will fur-
ther boost these numbers.
Besides the many genetic loci discovered for reserve-
related phenotypes through GWAS, two important fea-
tures additionally stand out. First, genetic correlation
testing has confirmed that reserve shares a substantial
genetic basis with dementia [87, 90, 91]. Second, some
genetic variants linked to both reserve, and ultimately
dementia, seem to exert their effect already early in life
[92], possibly even in utero [87]. Therefore, to develop
effective preventive and therapeutic strategies it is piv-
otal to understand the mechanism from gene through
reserve all the way to dementia and to do so across the
entire life-span, starting ideally prenatally.
Another relevant point is that most of the epidemio-
logical reserve-related factors are not independent but
are rather inter-related. For example, literacy is partially
genetically determined but it is also strongly affected by
educational experiences, social factors and other
environmental factors. For most, education is not strictly
environmental since subjects with higher intelligence
usually complete more years of schooling [43].
Occupational status is related to education, literacy and
socioeconomic factors but also represents a form of
non-formal education. Lifestyles and patterns of intellec-
tual, social and physical activities are related to
educational and occupational attainment and at the
same time represent a life-long type of training. This fur-
ther emphasises the need for longitudinal life course
studies that accurately capture these variables from birth
and onward.
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Twin studies indicate that many lifestyle attitudes,
such as eating patterns [93], smoking [94, 95], sports
participation and daily physical activity [96] and even re-
ligiosity [97, 98], might be influenced by genetic factors.
Therefore, although many of the epidemiological factors
affecting reserve are usually examined separately in the
scientific literature, they most likely represent conver-
gent or divergent constructs to some degree. Some fur-
ther factors (i.e. nutrition [99] and others), for which
there is strong epidemiological support for associations
with risk of cognitive decline and dementia, have not yet
been investigated within a reserve-type research frame-
work, e.g. exploring their mediating effects on the
association between disease-related brain changes and
symptoms due to those changes.
Reserve in non-Alzheimer’s disease disorders
The question of whether reserve is specific for a given dis-
ease or whether it is a phenomenon that can be observed
across different disorders is of prime importance both
theoretically and in practical terms. Most human data on
reserve in relation to cognitive decline comes from epi-
demiological studies of people with late onset dementia,
most of whom have a combination of AD-type pathology
and cerebrovascular changes.
In vascular dementia, a population-based study in dif-
ferent cohorts showed that higher education was associ-
ated with a risk reduction of dementia due to stroke,
indicating that education confers reserve and attenuates
the impact of stroke on cognitive function [100]. Bilin-
gualism, another factor associated with higher presumed
reserve, was also reported to be associated with better
cognitive function after stroke [101]. However, it needs
to be cautioned that, in subjects with higher education, a
healthier lifestyle is more frequently found, and thus the
individual contribution of different reserve proxies is dif-
ficult to estimate. In small vessel disease, higher educa-
tion attenuated the association between white matte
damage and cognitive function [102, 103].
There is also a growing body of evidence on the positive
effects of protective environmental factors in different
non-AD neurodegenerative disorders. FDG-PET studies
show that the negative impact of glucose metabolic defi-
cits on cognitive performance is attenuated by years of
schooling in AD [104, 105], behavioural variant FTD
[106], primary progressive aphasia [107] and dementia
with Lewy bodies [108]. The observation that metabolic
deficits have a smaller effect on cognitive function in men
compared to women (i.e. evidence for a sex-specific com-
ponent of reserve) has also been reported for different
neurodegenerative disorders, including AD [109] and be-
havioural variant FTD [110]. Taken together, these studies
suggest that certain aspects of reserve may be independent
from the underlying type of neurodegenerative pathology.
Outside the field of prototypical neurodegenerative
disorders, reserve has also been studied in other brain
conditions, in particular in MS. Environmental protective
factors, including a combination of educational attain-
ment, premorbid IQ and the participation in cognitive
leisure activities, were found to have a beneficial role in
preserving cognitive function and to moderate the effect
of structural brain damage on cognitive performance
[111], which is a repeated finding across several studies
[112]. Personality traits were also studied in MS in relation
to reserve and it was reported that conscientiousness had
a synergistic positive effect with childhood enrichment
activities on cognitive processing speed [113].
Evidence on the effects of reserve outside of the AD field
also exists for SZ. It was shown that higher reserve
(estimated by a combination of premorbid IQ, educational-
occupational level and leisure activities) was associated
with better cognitive (working memory and attention)
[114] and functional [115] outcomes after a 2-year
follow-up in individuals with a first episode of SZ, control-
ling for the influence of clinical psychopathology. Environ-
mental protective factors (education-occupation, leisure
activities) and premorbid IQ were also related to better
neuropsychological and psychosocial function in euthymic
patients with bipolar disorder cross-sectionally [116, 117],
further underpinning the notion that reserve is not an
AD-specific phenomenon.
Preclinical research and small animal studies
Despite a large and influential literature on the effects of
‘environmental enrichment’ on the brain [118–120], the
ideas of BR, CR and BM, which are implicit or even
explicit in these experimental studies on mice and rats,
have not yet been extensively discussed in basic neuro-
biological research; interdisciplinary comparative re-
search is essentially absent. The consequence is that the
neurobiological foundation of the various types of re-
serves that have been described often remains vague.
The exact morphological correlates of changes de-
tected in imaging studies are often not known and can
only be inferred. For example, determining white matter
integrity as a variable in MRI studies [121] does not
allow specific conclusions about the microstructure of
axons and myelin sheets, including their biochemistry
and physiology, which would require microscopy. Con-
versely, an experimental study on the plasticity of axons
will never inform about large-scale patterns of connect-
ivity that MRI is able to assess. Nevertheless, results
from basic research on the effects of physical activity or
environmental enrichment in animal models are often
extrapolated to the human situation and clinical context
without considering the limits of the analogy. These
findings imply that both lines of research can inform
and inspire each other.
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A main strength of animal studies in this domain is
that the genetic background can be controlled and the
environmental stimuli precisely dosed [122], allowing
the study of fundamental questions of gene-environment
interactions and increasing the likelihood of developing
mechanistic theories at the level of genes, signalling
molecules, synapses and cells. Such a reductionistic ap-
proach is necessary to condense the immense complex-
ity of reserve phenomena with respect to both gaining
profound and complete mechanistic insight and develop-
ing strategies to improve reserve formation in the med-
ical context [123]. The challenge remains on how to
transition from the reduced experimental situation to
the full depiction of individual human life. Additionally,
the degree of cognitive changes that can be observed in
rodents is quite small, further limiting the potential to
highlight substantial effects.
Adult hippocampal neurogenesis is a prime example
for brain plasticity. Within the mammalian brain, adult
neurogenesis in the hippocampus is an exception as
other brain regions do not show the lifelong generation
of new neurons [124]. The hippocampus as a key struc-
ture for memory formation, including autobiographic
memory, is often affected early in neurodegeneration
and dementia and is one of the best-studied brain re-
gions. New neurons do not contribute to hippocampal
function by allowing learning per se but by contributing
to the flexible integration of new information into
pre-existing contexts and the contextualisation of new
information [125, 126]. Importantly, adult hippocampal
neurogenesis is regulated by behavioural activity [124],
which creates the unique opportunity to study the
dynamics and mechanisms of a process of (cellular) brain
plasticity from genes and cells to behaviour, including the
relevant feedback loops.
The proposed ‘neurogenic reserve’, which describes
how an activity-dependent build-up of a potential for
neurogenesis maintains lifelong cognitive flexibility and
adaptability, does not replace or explain reserve forma-
tion and maintenance in other contexts but can still
serve as a role model [127]. In contrast, cortical synaptic
changes as a substrate of plasticity, and hence reserve,
will be much more widespread but also more diffuse,
less straightforward to study and even more variable in
their contribution to net effects. In the case of adult hippo-
campal neurogenesis, synaptic plasticity converges on the
newly formed cells in a highly defined network situation
that provides identifiable and relevant functionality [128].
Controlling both genetic background and the external
environment is possible in animal studies and allows ad-
dressing the impact of the so-called ‘non-shared envir-
onment’, namely the aspect of non-genetic factors that
drive brain plasticity according to individual behaviour
or exposure; thus, with adult neurogenesis as a primary
exemplary readout, ‘enriched environments’ can be de-
veloped into an experimental paradigm that captures the
biological essence of how an individual’s fate can be
shaped. Adult neurogenesis remains an intriguing, albeit
particular, example. What is missing are other equally
(or more) detailed examples of activity-dependent plasti-
city and their resulting feedback loops, which would
allow the generalisation across brain structures and
functional contexts and the development of solid and
broad neurobiologically founded reserve concepts.
Interventional studies
The identification of potentially modifiable risk factors for
AD, and dementia in general, has led to an increased inter-
est in testing non-pharmacological interventions based on
lifestyle modification with the ultimate aim to strengthen
reserve. An inherent conceptual difficulty in such trials
targeting reserve is the necessary time lag between the
intervention improving reserve and the ultimate effect in
reducing the risk of dementia. This explains the inconsist-
ency across trials that use, as the primary endpoint, either
cognitive decline, which does not necessarily need to inter-
fere with one’s daily functioning, or dementia diagnosed by
a physician according to a standard set of (clinical) criteria.
The search for other surrogate phenotypes as the primary
outcome, e.g. imaging, to overcome these concerns has not
yet yielded the expected results. Still, interventions target-
ing reserve have not been entirely disappointing.
Non-pharmacological clinical trials emerged in the
early 2000s and included cognitive training, physical ex-
ercise or nutritional interventions to reduce important
risk factors, for example, related to vascular health. A
detailed discussion of these interventions is beyond the
scope of this paper and available elsewhere [20, 129, 130].
Additionally, the results were mixed [131–133] and trials
progressively evolved towards multi-domain interventions
targeting several different lifestyle factors simultaneously,
in line with the multifactorial causes of AD. Findings from
recent prevention trials suggest that older individuals at
increased risk for developing dementia may benefit from
multi-domain intervention strategies to some extent; how-
ever, the effects of such interventions on cognitive and
functional outcomes remain to be well established [134,
135] and some studies have not been able to show any
benefit of multi-domain interventions [136, 137]. In
addition, it is questionable whether the same interventions
can be expected to affect different disorders, for example,
AD and FTD. Additionally, the existing data do not allow
differentiation between the neuroprotective and symptom-
atic effects of the interventions. Further biologically rooted
concepts are therefore needed.
The emotional and affective dimension of ageing has
thus far not been directly targeted in clinical trials. Yet,
depression is identified as a risk factor for AD [138],
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stress is associated with brain (especially hippocampal)
deterioration [139], and neuroticism and anxiety are as-
sociated with an increased cumulative incidence of de-
mentia [140, 141]. Therefore, mental training for stress
reduction and emotion and attention regulation could
have a beneficial effect on mental health and well-being
in ageing populations, and particularly in the reduction
of risk or delaying the onset of dementia.
Meditation practice is used to exemplify the potential
benefits of an intervention aiming to reduce stress.
Studies on this topic are scarce and have limitations
[142], but they indicate that meditation tends to have a
positive impact on attentional and memory capacities
[143], which are particularly relevant in the context of
ageing, AD and reserve. Similarly, the effects of medita-
tion on brain structure and function in young adults are
particularly marked in frontal and limbic structures, the
anterior cingulate cortex and insula [144, 145], all of
which are brain regions particularly sensitive to ageing
and AD and/or known to be involved in reserve-related
mechanisms [146–149].
In ageing, one previous study showed a less marked
grey matter volume reduction with age in meditation
practitioners compared to controls [150], and a pilot
study reported higher brain volume and glucose metab-
olism in meditators versus controls in areas of the
temporo-parietal and prefrontal cortex, insula, and pos-
terior and anterior cingulate [151], highlighting that me-
diation may offset the impact of age-associated changes
on brain function and structure, potentially leading to
reduced dementia risk. However, these observations and
assumptions will have to be experimentally confirmed in
clinical trials before firm conclusions can be drawn.
Putative functional brain mechanism
Although several protective environmental factors that
support reserve have been identified [24], the underlying
brain properties are not clear. Many investigators have
used functional imaging in order to address this issue.
An early paper suggested the study of potential neural
implementations of CR, neural reserve and neural com-
pensation [152]. Neural reserve refers to the cognitive
networks that are present in young people, and which
are influenced by ongoing life exposures. Thus, over
time, the efficiency, capacity or flexibility of these
network changes, and individual differences in these net-
works might constitute one implementation of CR.
When the brain is challenged by age- or disease-related
changes, those with more neural reserve would be able
to maintain function more easily. While the concept of
neural efficiency was developed in the context of im-
aging studies, it is closely aligned with the Scaffolding
Theory of Ageing and Cognition model, proposed as a
concept of cognitive ageing that integrates evidence
from structural and functional neuroimaging to explain
how the combined effects of adverse and compensatory
neural processes produce varying levels of cognitive
function [153]. Neural compensation refers to alterations
in the way that tasks are brought on by cerebral changes
due to ageing or disease that would not be typically seen
in a healthy individual. Higher CR could be associated
with the ability to recruit a compensatory network, or al-
ternatively, by the lack of the need to recruit this network.
Other conceptual models of compensation as a neural
mechanism contributing to reserve have been offered,
where any putative compensatory brain mechanism
should show a time-dependent quadratic change during
disease progression, with an initial increase in brain ac-
tivity and subsequent decline [154, 155]. These aspects
of compensation were mathematically formalised so that
the model becomes parameterised and testable [154],
and then applied to functional brain changes in
Huntington’s disease, an autosomal dominant disease as-
sociated with decline in motor and cognitive functions
[156, 157]. Those results highlight the power of predict-
ive models to uncover functional brain changes that sup-
port reserve.
Most of the studies of the neural implementation of
CR have used task-related activation paradigms. Often,
they have focused on the relationship of CR proxies to
differential efficiency, capacity or flexibility of brain
networks during task performance or to compensatory
recruitment. Since CR moderates between brain changes
and cognitive/clinical status, many studies have incorpo-
rated structural measures and assessments of Aβ and/or
tau pathology in addition to functional measures. For ex-
ample, in one study of cognitively normal older adults
with negative Aβ scans [158], higher education was re-
lated to greater volume and metabolism in the anterior
cingulate. Resting functional MRI (fMRI) connectivity
analysis showed greater connectivity as a function of
education between the anterior cingulate, hippocampus
and posterior cingulate, which was in turn associated
with better memory and executive function. The authors
concluded that reinforcement of the connectivity of the
anterior cingulate cortex with distant cortical areas of
the frontal, temporal and parietal lobes appears to be an
underlying mechanism for education-related reserve in
healthy elders.
More recent studies have identified a functional brain
substrate that attenuates the association between AD brain
pathology and cognitive impairment. A hypothesis-based
set of studies focused on the cognitive control network as a
putative network supporting reserve. Several fMRI studies
showed that a fronto-parietal cognitive control network, in
particular a hub in the left frontal cortex (BA44/6 in the
Broca area), is related to higher general cognitive perform-
ance in young subjects [159, 160]. The flexibly of this
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control network allows it to adapt its activity to task de-
mand [161]. In a series of resting-state and task-fMRI stud-
ies in ageing and different disease stages of AD, it was
demonstrated that higher connectivity of that hub in the
left frontal cortex (BA44/6) was related to higher reserve
[162–165]. In particular, at a higher resting-state left frontal
hub connectivity, the association between lower parietal
FDG-PET metabolism and episodic memory impairment
was ameliorated in sporadic and autosomal-dominant
AD [162, 166, 167].
The association between specific cognitive functions/
domains, certain brain pathologies and reserve-related
functional brain mechanisms also requires testing.
Population-based research suggests that CR may help
compensate for the effects of pathological changes
across individual cognitive functions. In line with these
findings, a ‘task-invariant’ CR network, which is acti-
vated during several different cognitive tasks, was re-
cently described. A multivariate network which is active
during different cognitive tasks, and which also corre-
lates with IQ (a surrogate measure of CR) was derived
[168]. The activation of this network also explained
some of the performance in fluid reasoning, which was
not exclusively related to brain structural characteristics
such as cortical thickness. Another future step is to
combine different dimensions of putative brain changes,
such as regional grey matter volume and fibre tract-
based structural connectivity, with functional brain
changes to establish a fully integrated model of neural
mechanisms underlying reserve.
Conclusions
The dementia field has undergone a substantial change
in recent years. Traditional clinical disease models are
being transformed to more biologically oriented classifi-
cations [169]. These changes are fuelled by the urgent
desire to develop disease-modifying treatments, which
require pathophysiological targets to be effective. The
combination of national biobank and cohort resources
with innovative analytics is a promising approach to-
wards this goal. An important finding of epidemiological
research is that dementia and ageing are intimately
related processes, both of which lead to the progressive
accumulation of organ damage and detrimental bio-
logical changes.
There is ample evidence that AD (co-)pathology is the
most prevalent pathological change in older individuals
with dementia, and there is a credible link between
AD-type pathology and cognitive/clinical decline. How-
ever, studies also show that this relationship is weaker in
the eldest elderly [170]. The assumption of clear-cut de-
mentia subtypes is put into question by biomarker and
neuropathological research suggesting that a substantial
proportion of clinically ‘pure’ AD cases have mixed
pathology at autopsy (e.g. additional cerebrovascular
lesions) and that Aβ is commonly found in cognitively
normal older adults [171].
Population-based research stresses the importance of
environmental and lifestyle-related factors in the complex
risk structure of dementia. Lifestyle characteristics appear
to be particularly relevant if they are in effect during
middle age and many of those factors are associated with
vascular health [172]. Reduced vascular burden, better
educational systems and other beneficial societal changes
during the last 20 to 30 years may underlie the repeatedly
reported decreasing age-associated dementia prevalence
and incidence in high-income countries [173, 174] versus
rapidly increasing dementia numbers in lower-income
countries [175]. Vascular disease probably explains a sig-
nificant part of dementia risk in individuals older than 75
years and pathologies in older people are likely mixed in
most instances [176].
The improved knowledge about the epidemiological
risk structure of dementia has so far not been success-
fully translated into effective dementia prevention pro-
grammes and there is an ongoing debate about the
causality of important risk factors [177, 178]. However,
there still is value in identifying which lifestyle and med-
ical factors are potentially modifiable and general practi-
tioners should play a central role in promoting lifestyle
changes likely to reduce dementia risk in the population.
Despite the implementation of national campaigns, the
awareness of links between health-related behaviour and
dementia risk is low in the general population [179], and
only little is known about the knowledge of primary care
staff on risk factors or to what extent such topics are
discussed with patients [180]. The overlap with cardio-
vascular and diabetes risk suggests that dementia should
be added to existing chronic disease prevention initia-
tives already located in primary care.
To implement more effective dementia prevention
programmes globally, the fragmented population-based
research landscape needs to be more closely aligned, key
relationships between societal, psychological and bio-
logical risk factors for dementia have to be explored in
more detail, and research has to cross the borderlines
between the traditional dementia types and aetiologies.
A considerable movement across scientific domains and
geographical areas to collect longitudinal data and estab-
lish comprehensive data repositories for information
sharing is currently underway. Projects such as the
Health and Retirement Study at the University of
Michigan (https://hrs.isr.umich.edu/), which prospect-
ively surveys a representative sample of over 20,000
older Americans, will offer valuable multifaceted infor-
mation to address key questions about the challenges,
but also the opportunities, of ageing. Platforms such as
the Gateway to Global Aging (https://g2aging.org/),
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the Global AD Association Interactive Network
(http://www.gaain.org/) and the European Medical In-
formation Framework (http://www.emif.eu/) offer the re-
quired infrastructure to pool population surveys and
patient-level data to support innovative, large-scale re-
search. These and other similar multinational efforts help
to harmonise data across the individual studies and to fos-
ter collaboration and data sharing. These efforts will help
to address critical questions in relation to clinical, genetic,
omics and other data, which are also relevant for research
on reserve and which can currently not be answered in
any single cohort.
Recommendations and future perspectives
Based on a thorough qualitative review of important as-
pects of the reserve literature, our group has agreed on a
list of key consensus recommendations that, in our opin-
ion, would help research efforts in this field to provide
more informative results with more tangible benefits for
the affected or at-risk of disease populations. Firstly, it is
crucial that the field reaches consensus on conceptual
research models to be used when exploring the different
concepts of reserve. For CR one must keep in mind that
experiences considered proxies of CR moderate between
brain and cognitive changes. For example, in imaging
studies designed to explore CR, it is important to keep
the level of BR in mind. That is, differential task-related
activation occurs in the context of measurable important
brain variables, for example, including volume, cortical
thickness and white matter tract integrity [181].
CR-related activation patterns should optimally moder-
ate between these brain measures and cognition. Con-
certed efforts to harmonise research in the reserve field
have to be increased, including regular expert meetings
(e.g. Alzheimer’s Association Reserve and Resilience
Professional Interest Area), consensus conferences (e.g.
Conference on Cognitive Reserve in the Dementias) and
the publication of evidence-based guidelines [14, 182].
Secondly, along with consensus on concept definitions
and research approaches is the need for replication of
research findings in ‘test bed’ datasets. For example, if a
particular resting fMRI pattern is considered a candidate
for a neural representation of CR, it optimally should
moderate between brain and cognitive measures. It
would be ideal to have standard, shared sets of data that
could be used for these types of analyses. Thus, as
groups begin to collect extensive longitudinal datasets,
establishing opportunities for sharing and for an appli-
cation of results across datasets will be crucial. The
continued improvement of IT platforms, such as the
Global Alzheimer’s Association Interactive Network
and the European Medical Information Framework, will
improve the availability of larger and more diverse sets
of data.
Thirdly, advances will be facilitated by collaboration
and comparison of results by different laboratories. The
substantial heterogeneity of human genetic and environ-
mental factors dictates such collaboration, which can
only be achieved after similar methods of data collection
and analysis are agreed upon by the research commu-
nity. Pooling of data into publicly accessible repositories
will empower more scientists globally to work on the
valuable information sources. Databases such as the
International Alzheimer’s and Related Dementias Re-
search Portfolio (https://iadrp.nia.nih.gov/about), which
collates and categorises the portfolios of major funding
organisations for areas of shared priorities as well as
areas of opportunities to inform coordination and collect-
ive efforts that seek to advance dementia research, help to
coordinate funding strategies and leverage resources in
order to maximise the impact on public health and to
avoid duplication of effort and reduce inefficiency. How-
ever, such efforts will need to be proceeded by the estab-
lishment of appropriate ethical, legal and social rules and
agreements accepted across regional and cultural bound-
aries, as advocated by the World Dementia Council
(https://worlddementiacouncil.org/our-work/our-work),
for instance.
Fourthly, it will also be crucial for studies of the differ-
ent reserve concepts to move towards longitudinal and,
if possible, interventional studies. In these contexts, BM
can be directly evaluated and the moderating effects of
CR on cognitive or clinical outcomes can be better eluci-
dated. Efforts to translate the knowledge on epidemio-
logical risk and protective factors to clinical research has
so far largely been disappointing, and globally coordinated
randomised clinical trials are needed to explore if inter-
ventions targeting these risk factors can reduce the burden
of neurodegenerative diseases in the population [130].
Finally, we need to establish ‘cross talk’ between hu-
man and animal studies of these concepts. Experimental
neurobiological basic research of the different concepts
could improve mechanistic insights. Critical con-
structs such as maintenance, plasticity and flexibility can
be explored at the synaptic, cellular and functional level.
This would allow us to approach fundamental questions
about the relationship between brain structure and func-
tion. In addition, they may supply mechanistic insight
into the ideas embodied in the hypotheses of CR, BR
and BM. Typically, animal models of AD overexpress
human autosomal-dominant genes, which result in over-
production of Aβ. However, these models only capture
one, albeit central, aspect of AD pathology and other as-
pects, such as tau neurofibrils, are not adequately repre-
sented [183]. The premature translation of successful
animal experiments to human trials has contributed to
the high failure rate of AD drug development. Applying
knowledge from animal research to human research on
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reserve carries the same risk of failure. Our understand-
ing of the strengths and weaknesses of each of the differ-
ent disease models has to improve before we are in a
position of successful translational research in the de-
mentia space. The combination of more than one animal
model and studies of longer duration to explore relevant
disease and reserve mechanisms would help increase the
success of translational research. Another challenge of
translating findings from animal research to human
studies is related to the assessment of cognitive function
across the different species. For example, humans are
able to categorise and express their memory experience,
but it is far more difficult to establish reliable evidence
of episodic memories in animals since they are unable to
verbally communicate conscious recollection. Equivalent
measures of similar cognitive domains in animals and
humans are important to improve our understanding of
similarities and differences between biological models
and human disease. Therefore, developing more appro-
priate animal cognitive tests is another important pre-
requisite for successful translational research in the
reserve field.
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